Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer

INTRODUCTION: Androgen deprivation therapy (ADT) is a mainstay of treatment against advanced prostate cancer (PC). As a treatment goal, suppression of plasma testosterone levels to <50 ng/dl has been established over decades. Evidence is growing though that suppression to even lower levels may ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Breul, Jürgen, Lundström, Eija, Purcea, Daniela, Venetz, Werner P., Cabri, Patrick, Dutailly, Pascale, Goldfischer, Evan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331090/
https://www.ncbi.nlm.nih.gov/pubmed/28028737
http://dx.doi.org/10.1007/s12325-016-0466-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331090/
https://www.ncbi.nlm.nih.gov/pubmed/28028737
http://dx.doi.org/10.1007/s12325-016-0466-7

Ejemplares similares